15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)

被引：0

作者：

Aminian, Ali ^{[1
]}

ALJabri, Abdullah ^{[1
]}

Wang, Sarah ^{[1
]}

Bena, James ^{[1
]}

Allende, Daniela ^{[1
]}

Rosen, Hana ^{[1
]}

Wilson, Rickesha ^{[1
]}

Milinovich, Alex ^{[1
]}

Loomba, Rohit ^{[2
]}

Sanyal, Arun J. ^{[3
]}

Alkhouri, Naim ^{[4
]}

Wakim-Fleming, Jamile ^{[1
]}

Dasarathy, Srinivasan ^{[1
]}

McCullough, Arthur ^{[1
]}

Nissen, Steven ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland, OH USA

[2] Univ Calif San Diego, La Jolla, CA USA

[3] Virginia Commonwealth Univ, Richmond, VA USA

[4] Arizona Liver Hlth, Phoenix, AZ USA

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-125

引用

页码：S76 / S77

页数：2

共 50 条

[21] ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
Kim, Do Han
Ko, Donghyun
Corral, Juan E.
Kroner, Paul T.
Lukens, Frank
Argueta, Pedro Palacios
GASTROENTEROLOGY, 2024, 166 (05) : S1663 - S1664
[22] LIVER-RELATED OUTCOMES OVER 15 YEARS FOLLOWING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS DIAGNOSIS
Averitt, Amelia
Banerjee, Nilanjana
Li, Dadong
Wei, Henry
Lotta, Luca
Seth, Abhinav
Cantor, Michael
HEPATOLOGY, 2024, 80 : S832 - S832
[23] Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
Younossi, Zobair M.
Mangla, Kamal Kant
Berentzen, Tina Landsvig
Grau, Katrine
Kjaer, Mette Skalshoi
Ladelund, Steen
Nitze, Louise Maymann
Coolbaugh, Crystal
Hsu, Chih-Yuan
Hagstrom, Hannes
HEPATOLOGY COMMUNICATIONS, 2024, 8 (06)
[24] STATIN THERAPY AND IMPROVED WAITLIST OUTCOMES IN LIVER TANS PANT CANDIDATES WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS
Cooper, Katherine M.
Patel, Ami K.
Colletta, Alessandro
Devuni, Deepika
GASTROENTEROLOGY, 2024, 166 (05) : S28 - S28
[25] Evaluating the Impact of Cenicriviroc in Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Systematic Review
Singh, Avneet
Garcia, Alexander
Hasan, Fariha
Laique, Fatima
Mohiuddin, Mubashir
Haris, Muhammad
Abidi, Zehara
Jover, Queenzy
Awadallah, Mina
Wakil, Ali
Nguyen, Tommy
Roy, Satyajeet
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1249 - S1250
[26] Fasting Insulin as an Independent Predictor of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Severity
Harrison, Stephen A.
Dubourg, Julie
Jeannin, Sophie
Colca, Jerry R.
Ratziu, Vlad
DIABETES, 2024, 73
[27] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
Joung, Hyunchae
Joo, Jaeryang
Kim, KyungHwan
Shin, Chang Hun
Lee, Hye Won
HEPATOLOGY, 2024, 80 : S788 - S789
[28] THERAPEUTIC HORIZONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE( MASLD) & METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS( MASH): A SYSTEMATIC REVIEW OF CURRENT TREATMENT OPTION
Moliya, Pratiksha
Al-Obaidi, Hasan
Patel, Pranav
Patel, Raj
Parikh, Charmy
Joy, Melvin
HEPATOLOGY, 2024, 80
[29] Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
Sanyal, Arun J.
Husain, Mansoor
Diab, Crystel
Mangla, Kamal Kant
Shoeb, Ahsan
Lingvay, Ildiko
Tapper, Elliot B.
AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2024, 41
[30] Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
Saito, Takashi
Tsuchishima, Mutsumi
Tsutsumi, Mikihiro
George, Joseph
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (12)

← 1 2 3 4 5 →